BiomX Inc. (PHGE)
NYSEAMERICAN: PHGE · Real-Time Price · USD
0.8754
-0.1646 (-15.83%)
At close: Jun 2, 2026, 4:00 PM EDT
0.8596
-0.0158 (-1.80%)
Pre-market: Jun 3, 2026, 6:35 AM EDT

BiomX Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-47.68-36.2-17.73-26.17-28.32-36.23
Depreciation & Amortization
2.692.921.80.872.522.57
Stock-Based Compensation
-0.52.091.851.061.533.24
Other Adjustments
13.114.82-17.930.48-0.370.23
Changes in Accounts Payable
0.111.24-3.170.56-1.980.43
Changes in Accrued Expenses
-2.96-3.43-0.981.19-3.30.67
Changes in Unearned Revenue
---1.98--1.98
Changes in Other Operating Activities
0.512.171.160.730.82-0.45
Operating Cash Flow
-23.09-26.39-36.98-21.29-29.09-27.57
Capital Expenditures
-0-0-0.03-0.05-0.11-3.68
Sale of Property, Plant & Equipment
0.060.110.0800.010
Purchases of Investments
-----13.5-
Proceeds from Sale of Investments
---211.519.85
Other Investing Activities
-1-0.66---
Investing Cash Flow
-0.940.110.721.95-2.1116.17
Long-Term Debt Issued
-----14.23
Long-Term Debt Repaid
---10.75-4.25--
Net Long-Term Debt Issued (Repaid)
---10.75-4.25-14.23
Issuance of Common Stock
1.3113.3128.777.490.2923.06
Net Common Stock Issued (Repurchased)
1.3113.3128.777.490.2923.06
Issuance of Preferred Stock
2.62-21.27---
Net Preferred Stock Issued (Repurchased)
2.62-21.27---
Other Financing Activities
-0.03-0.12-0.92-0.33--
Financing Cash Flow
3.913.1938.372.90.2937.28
Effect of Exchange Rate Changes on Cash and Cash Equivalents
0.070.0700.010.11-0.03
Net Cash Flow
-20.13-13.092.11-16.44-30.9125.88
Free Cash Flow
-23.09-26.39-37.01-21.34-29.2-31.26
Free Cash Flow Per Share
-11.69-16.18-48.84-78.97-185.86-228.33
Levered Free Cash Flow
-47.34-33.3-31.67-27.13-30.36-20.5
Unlevered Free Cash Flow
-34.67-38.58-47.75-22.07-29.33-34.03
SEC Filings: 10-K · 10-Q